EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 59 filers reported holding EIDOS THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,039,000 | +71.5% | 7,900 | -34.2% | 0.00% | +33.3% |
| Q3 2020 | $606,000 | +5.9% | 12,000 | 0.0% | 0.00% | +50.0% |
| Q2 2020 | $572,000 | +1.6% | 12,000 | +4.3% | 0.00% | -33.3% |
| Q1 2020 | $563,000 | -14.6% | 11,500 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $659,000 | -21.5% | 11,500 | -50.9% | 0.00% | +50.0% |
| Q3 2019 | $840,000 | +131.4% | 23,400 | +100.0% | 0.00% | 0.0% |
| Q2 2019 | $363,000 | +640.8% | 11,700 | +457.1% | 0.00% | – |
| Q1 2019 | $49,000 | +75.0% | 2,100 | 0.0% | 0.00% | – |
| Q4 2018 | $28,000 | +40.0% | 2,100 | 0.0% | 0.00% | – |
| Q3 2018 | $20,000 | – | 2,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|